Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Ivan Fedorin"'
Autor:
Vladyslav Nikolayevskyy, Krishna Gopaul, Yanina Balabanova, Timothy Brown, Ivan Fedorin, Francis Drobniewski
Publikováno v:
Emerging Infectious Diseases, Vol 12, Iss 9, Pp 1406-1413 (2006)
A high prevalence of tuberculosis (TB) isolates that are genetically homogenous and from the Beijing family has been reported in Russia. To map TB transmission caused by these strains, new genotyping systems are needed. Mycobacterial interspersed rep
Externí odkaz:
https://doaj.org/article/3d79aaeceb4a48659f057ecc6f379511
Autor:
Francis Drobniewski, Yanina Balabanova, Michael Ruddy, Laura Weldon, Katya Jeltkova, Timothy Brown, Nadezdna Malomanova, Elvira Elizarova, Alexander Melentyey, Ebgeny Mutovkin, Svetlana Zhakharova, Ivan Fedorin
Publikováno v:
Emerging Infectious Diseases, Vol 8, Iss 11, Pp 1320-1326 (2002)
Consecutive patient cultures (140) of Mycobacteriium tuberculosis were collected from five Russian civilian and prison tuberculosis laboratories and analyzed for rifampin (rpoB) and isoniazid resistance (inhA, katG, ahpC); transmission of Beijing fam
Externí odkaz:
https://doaj.org/article/3a4e1b2a8f764ddaad7938ac1878b1e5
Autor:
Yanina Balabanova, Vladyslav Nikolayevskyy, Olga Ignatyeva, Irina Kontsevaya, Clare M Rutterford, Anastasiya Shakhmistova, Nadezhda Malomanova, Yulia Chinkova, Svetlana Mironova, Ivan Fedorin, Francis A Drobniewski
Publikováno v:
PLoS ONE, Vol 6, Iss 6, p e20531 (2011)
OBJECTIVE AND METHODS: A long-term observational study was conducted in Samara, Russia to assess the survival and risk factors for death of a cohort of non-multidrug resistant tuberculosis (non-MDRTB) and multidrug resistant tuberculosis (MDRTB) civi
Externí odkaz:
https://doaj.org/article/7fc3ab9242124c0c93e98b29866da3ad
Autor:
Yanina Balabanova, Francis Drobniewski, Vladyslav Nikolayevskyy, Annika Kruuner, Nadezhda Malomanova, Tatyana Simak, Nailya Ilyina, Svetlana Zakharova, Natalya Lebedeva, Heather L Alexander, Rick O'Brien, Hojoon Sohn, Anastasia Shakhmistova, Ivan Fedorin
Publikováno v:
PLoS ONE, Vol 4, Iss 9, p e7129 (2009)
ObjectiveTo analyse the feasibility, cost and performance of rapid tuberculosis (TB) molecular and culture systems, in a high multidrug-resistant TB (MDR TB) middle-income region (Samara, Russia) and provide evidence for WHO policy change.MethodsPerf
Externí odkaz:
https://doaj.org/article/96a78f8c3f25405b868d9755bf8517d4
Autor:
Francis Drobniewski, Yanina Balabanova, Elena Zakamova, Vladyslav Nikolayevskyy, Ivan Fedorin
Publikováno v:
PLoS Medicine, Vol 4, Iss 2, p e55 (2007)
BACKGROUND: Russia is one of 22 high burden tuberculosis (TB) countries. Identifying individuals, particularly health care workers (HCWs) with latent tuberculosis infection (LTBI), and determining the rate of infection, can assist TB control through
Externí odkaz:
https://doaj.org/article/bddaebfed7564781ac9fa902eb207642
Autor:
Francis Drobniewski, Krishna K. Gopaul, Vladyslav Nikolayevskyy, Ivan Fedorin, Yanina Balabanova, Tim Brown
Publikováno v:
Emerging Infectious Diseases
Scopus-Elsevier
Emerging Infectious Diseases, Vol 12, Iss 9, Pp 1406-1413 (2006)
Scopus-Elsevier
Emerging Infectious Diseases, Vol 12, Iss 9, Pp 1406-1413 (2006)
A new panel of 25 VNTR-MIRU loci differentiates Beijing-family TB strains better than a panel of 15.
A high prevalence of tuberculosis (TB) isolates that are genetically homogenous and from the Beijing family has been reported in Russia. To map
A high prevalence of tuberculosis (TB) isolates that are genetically homogenous and from the Beijing family has been reported in Russia. To map
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22befdce6b5f4ec292dc6b52451fb5be
http://europepmc.org/articles/PMC3294723
http://europepmc.org/articles/PMC3294723
Autor:
Ivan Fedorin, Ya. M. Balabanova, R. Koker, S. I. Kuznetsov, M. Raddy, Rifat Atun, K. Grem, A. V. Zhestkov, F. Drobnevsky, N. N. Kryukov
Publikováno v:
PULMONOLOGIYA. :87-92
Irrational administration of antimicrobials, incorrect regimens and dosing provide occurrence of adverse effects with minimal therapeutic results and development of drug resistance including anti-tuberculosis drugs. The study was designed to detect i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::341e75d2c80f925245d20c8d06280bc8
https://doi.org/10.18093/0869-0189-2005-0-1-87-92
https://doi.org/10.18093/0869-0189-2005-0-1-87-92
Autor:
Vladyslav Nikolayevsky, Ivan Fedorin, Tim Brown, M. Ruddy, Francis Drobniewski, Y. Balabanova
Publikováno v:
Journal of Clinical Microbiology. 42:4498-4502
High incidence rates of isoniazid-, rifampin-, and multiple-drug-resistant tuberculosis have been reported in countries of the former Soviet Union (FSU). Genotypic (unlike phenotypic) drug resistance assays do not require viable cultures but require
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8ca6a88e887e60b8d617532811110ac
https://doi.org/10.1128/jcm.42.10.4498-4502.2004
https://doi.org/10.1128/jcm.42.10.4498-4502.2004
Autor:
Yanina Balabanova, Catriona Graham, Rifat Atun, Ivan Fedorin, Sergey G. Kuznetsov, Richard Coker, M Ruddy, Francis Drobniewski
Publikováno v:
Journal of Antimicrobial Chemotherapy. 54:673-679
Inappropriate antibiotic prescribing exposes patients to the risk of side effects and encourages the development of drug resistance across antimicrobial groups used for respiratory infections including tuberculosis (TB).Determine among Russian genera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6eb860c3ba71a021a873105f8e49cc79
https://doi.org/10.1093/jac/dkh383
https://doi.org/10.1093/jac/dkh383
Autor:
Vladyslav, Nikolayevskyy, Yanina, Balabanova, Tatyana, Simak, Nadezhda, Malomanova, Ivan, Fedorin, Francis, Drobniewski
Publikováno v:
BMC Clinical Pathology, Vol 9, Iss 1, p 2 (2009)
BMC Clinical Pathology
BMC Clinical Pathology
Background Russia is a high tuberculosis (TB) burden country with a high prevalence of multidrug resistant tuberculosis (MDRTB). Molecular assays for detection of MDRTB on clinical specimens are not widely available in Russia. Results We performed an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::645c71c1f21ffa994f88f67a6854d87d
http://www.biomedcentral.com/1472-6890/9/2
http://www.biomedcentral.com/1472-6890/9/2